Shares for a cannabis company spiked 324% after the FDA said it could apply to run a clinical trial of its marijuana-derived drug to treat coronavirus patients
FSD Pharma received approval from the FDA to apply to run a clinical trial of a cannabis-derived drug on coronavirus patientsThe drug mimics molecules naturally found in marijuana that bind to…